|
IAC Express 2008 |
| Issue number 735: June 9, 2008 |
| |
Contents
of this Issue
Select a title to jump to the article. |
- CDC's
recommendations for preventing herpes zoster (shingles) now published as
an MMWR Recommendations and Reports
- CDC
reports on hospital-acquired pertussis among newborns in Texas in 2004
- FDA
approves use of Tenivac tetanus and diphtheria toxoids in adults age 60
years and older
- Two
hepatitis B parent-education resources now available in Spanish and six
additional languages
- Update:
IAC revises its "Emergency Response Worksheet"
-
Correction: June 2 IAC Express had incorrect URL for ordering vaccination
resources from the Vaccine Education Center (VEC)
- The
Vaccine Quarterly provides an evidence-based academic review of timely
vaccine-related issues
- AMA
offers physicians practical information on improving adolescent
immunization
- Two
comprehensive sharps injury prevention resources are available--one on
CD-ROM, the other for downloading
- New:
Interim VIS for MMR vaccine now available in Thai
-
PowerPoint presentations now available from the National Conference on
Immunization and Health Coalitions
- Seminar
on CMI techniques standardization for vaccine response evaluation is
planned for September 15-17 in Annecy, France
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 735: June 9, 2008 |
|
|
|
1. |
CDC's recommendations for preventing herpes zoster (shingles) now published
as an MMWR Recommendations and Reports
On June 6, CDC published "Prevention of Herpes
Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)"
as an MMWR Recommendations and Reports. Previously, the recommendations were
available only in electronic format as an MMWR Early Release (published May
15). There is no difference in the content of these two documents; the
content of the MMWR Recommendations and Reports published on June 6 is
identical to the content of the MMWR Early Release published on May 15.
Important note: If you bookmarked these recommendations based on the URL
given in the MMWR Early Release, please change your bookmark to reflect the
URL below.
To access a ready-to-print (PDF) version of the recommendations, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5705.pdf
Note: The PDF version includes a free CDC-sponsored education activity that
can be completed online or submitted by fax or U.S. mail for continuing
education credit. Simply read the recommendations, answer the questions at
the end, and follow instructions for submitting your answers.
To access a web-text (HTML) version of the recommendations, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5705a1.htm
To receive a FREE electronic subscription to MMWR (which includes new ACIP
recommendations), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
| |
|
|
2. |
CDC reports on hospital-acquired pertussis among newborns in Texas in 2004
CDC published "Hospital-Acquired Pertussis Among
Newborns--Texas, 2004" in the June 6 issue of MMWR. Portions of the
article are reprinted below.
On July 10, 2004, staff members at a children's hospital in
Texas noted that six infants with pertussis diagnosed by
clinical symptoms and confirmed by polymerase chain reaction
(PCR) testing had all been born during June 4-16 at the same
area general hospital. The infants had symptoms consistent with
pertussis, including cough, congestion, cyanosis, emesis, or
apnea. Infection-control personnel at the general hospital
(general hospital A), children's hospital (children's hospital
A), and the county health department investigated and determined
that an outbreak of pertussis among 11 newborns at general
hospital A had occurred after direct exposure to a healthcare
worker (HCW) with pertussis. This report describes the outbreak
investigation and highlights the importance of following
recommendations to administer tetanus toxoid, reduced diphtheria
toxoid, and acellular pertussis (Tdap) vaccine to HCWs to
prevent transmission of pertussis to patients.
Immediately after identification of the six infants with
pertussis at children's hospital A, hospital staff members
reviewed newborn nursery charts at general hospital A. One staff
member (HCW A) was identified as having directly cared for all
six infants during their stay in the newborn nursery. Review of
work logs for all shifts identified four additional hospital
workers who had been present while the six infants were in the
newborn nursery.
From early to mid-June until July 17, while working in the
newborn nursery at general hospital A, HCW A had exhibited
symptoms of pertussis, including cough, posttussive emesis, and
dyspnea. Her spouse reportedly had similar symptoms after he
returned from a trip to California, 2-3 weeks before HCW A
began exhibiting her symptoms. HCW A, aged 24 years, had been
fully vaccinated for pertussis during early childhood. HCW A and
a nursery coworker with cough symptoms were tested for
pertussis by PCR; only HCW A tested positive. On July 17,
HCW A was furloughed from general hospital A for 5 days and
treated with erythromycin. Her husband also was prescribed
erythromycin. . . .
The review of laboratory records and charts at children's
hospital A revealed that 29 infants aged <4 months met the case
definition for pertussis during June-August. Of these 29
infants, 11 (including the six previously known patients) had
been born at general hospital A and directly exposed to HCW A in
the newborn nursery. All 11 had been treated at children's
hospital A with erythromycin and recovered; none developed
hypertrophic pyloric stenosis, which has been reported as a
complication of treatment of infants with erythromycin. Five of
the infants required admission to the pediatric intensive-care
unit (PICU), and four were treated in the general pediatric
medical unit; one infant was treated in the emergency
department, and one was treated as an outpatient. Median age of
the 11 infants born at general hospital A was 31 days at the
time of pertussis diagnosis, compared with a median age of 61
days for the other 18 infants with diagnosed pertussis, who were
born at 12 other general hospitals during June-August. . . .
In 2005, Tdap vaccine was licensed by the Food and Drug
Administration for use in adolescents and adults. In December
2006, the Advisory Committee on Immunization Practices (ACIP)
recommended use of Tdap vaccine for HCWs with direct patient
contact and for adults who have or might have close contact with
infants aged <12 months. This recommendation was based on the
documented risk for transmission of pertussis in healthcare
facilities. Despite the costs involved for healthcare
facilities, one study suggests the return on investment from
vaccinating HCWs with Tdap vaccine is twice the cost of the
vaccine.
Widespread implementation of Tdap vaccination of adolescents and
adults as recommended by ACIP can reduce the risk for pertussis
in the community and the incidence of pertussis transmission in
healthcare facilities. This outbreak also highlights the
importance of rapid recognition of pertussis transmission in
healthcare settings and rapid response from hospital and public
health practitioners to identify the source and prevent more
extensive spread of disease, particularly among vulnerable
newborns and infants.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5722a2.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5722.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
| |
|
|
3. |
FDA approves use of Tenivac tetanus and diphtheria toxoids in adults age 60
years and older
On June 5, the Food and Drug Administration (FDA)
approved the
use of sanofi pasteur's Tenivac tetanus and diphtheria toxoids
adsorbed for adults age 60 years and older. In the original
licensure, the age indication was for persons ages 7-59 years.
To view the supplemental license approval information on the FDA
website, go to:
http://www.fda.gov/cber/approvltr/tenivac060608L.htm
To read the package insert, go to:
http://www.fda.gov/cber/label/tenivaclb.pdf
Back to top |
| |
|
|
4. |
Two hepatitis B parent-education resources now available in Spanish and six
additional languages
IAC now offers two of its popular hepatitis B
parent-education
print resources in languages in addition to English. "Hepatitis
B Shots Are Recommended for All New Babies" is available in
Spanish, Arabic, Chinese, French, Korean, Russian, and
Vietnamese. "All Kids Need Hepatitis B Shots" is available in
Spanish, Chinese, Hmong, Korean, Russian, Tagalog, and
Vietnamese. IAC gratefully acknowledges the California
Department of Public Health, Immunization Branch, for the
translations of "All Kids Needs Hepatitis B Shots." Links to all
translations of both print resources follow.
"HEPATITIS B SHOTS ARE RECOMMENDED FOR ALL NEW BABIES"
For a Spanish version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110-01.pdf
For an Arabic version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110-20.pdf
For a Chinese version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110-08.pdf
For a French version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110-10.pdf
For a Korean version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110-09.pdf
For a Russian version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110-07.pdf
For a Vietnamese version of "Hepatitis B Shots Are Recommended
for All New Babies," go to:
http://www.immunize.org/catg.d/p4110-05.pdf
For an English version of "Hepatitis B Shots Are Recommended for
All New Babies," go to:
http://www.immunize.org/catg.d/p4110.pdf
"ALL KIDS NEED HEPATITIS B SHOTS"
For a Spanish version of "All Kids Need Hepatitis B Shots," go
to:
http://www.immunize.org/catg.d/p4055-01.pdf
For a Chinese version of "All Kids Need Hepatitis B Shots," go
to:
http://www.immunize.org/catg.d/p4055-08.pdf
For a Hmong version of "All Kids Need Hepatitis B Shots," go to:
http://www.immunize.org/catg.d/p4055-02.pdf
For a Korean version of "All Kids Need Hepatitis B Shots," go
to:
http://www.immunize.org/catg.d/p4055-09.pdf
For a Russian version of "All Kids Need Hepatitis B Shots," go
to:
http://www.immunize.org/catg.d/p4055-07.pdf
For a Tagalog version of "All Kids Need Hepatitis B Shots," go
to:
http://www.immunize.org/catg.d/p4055-06.pdf
For a Vietnamese version of "All Kids Need Hepatitis B Shots,"
go to: http://www.immunize.org/catg.d/p4055-05.pdf
For an English version of "All Kids Need Hepatitis B Shots," go
to: http://www.immunize.org/catg.d/p4055.pdf
To access more than 175 FREE print resources for healthcare
professionals and the public from IAC's Print Materials web
section, go to: http://www.immunize.org/printmaterials
Back to top |
| |
|
|
5. |
Update: IAC revises its "Emergency Response Worksheet"
IAC recently updated "Emergency Response
Worksheet," a print
resource that outlines the steps healthcare professionals should
take if a power failure or other event results in vaccine
storage outside of the recommended temperature range. Updates
were made to the telephone numbers of vaccine manufacturers.
To access the revised "Emergency Response Worksheet," go to:
http://www.immunize.org/catg.d/p3051.pdf
To access more than 175 FREE print resources for healthcare
professionals and the public from IAC's Print Materials web
section, go to: http://www.immunize.org/printmaterials
Back to top |
| |
|
|
6. |
Correction: June 2 IAC Express had incorrect URL for ordering vaccination
resources from the Vaccine Education Center (VEC)
The June 2 issue of IAC Express included an
article titled
"Free: VEC offers sample quantities of new adult and teen
vaccination resources at no charge." The article gave readers
the incorrect link to the healthcare professionals' ordering
page. IAC Express regrets the error and any inconvenience it may
have caused the Vaccine Education Center and our readers.
The correct URL is
https://www.chop.edu/vaccine/vec/vecprof_order.cfm
Back to top |
| |
|
|
7. |
The Vaccine Quarterly provides an evidence-based academic review of timely
vaccine-related issues
Begun in March 2007, The Vaccine Quarterly (TVQ)
provides an
authoritative, academic, evidence-based review of timely
vaccine-related issues of interest to practitioners. Published
by Lippincott and approved by the Lippincott CME Institute, it
is a continuing education (CE) publication that awards CE
credits to physicians. TVQ became available on the Internet in
December 2007.
The editor is Gary S. Marshall, MD, professor of pediatrics;
chief, Division of Pediatric Infectious Diseases, University of
Louisville School of Medicine, Louisville, KY.
Each issue includes the following:
(1) Literature reviews: Members of the editorial board review
eight articles published in the primary scientific literature in
the previous 3-6 months. TVQ publishes a summary of each article
and a comment section that includes a critique of the science
and a discussion of the implications.
(2) Editor's section: This highlights up-to-the-minute vaccine
news, including licensures, ACIP recommendations, outbreaks, and
other notable immunization happenings.
(3) Invited guest article: Each issue contains one informative,
concise review/opinion piece on a hot topic written by an
invited guest.
To access The Vaccine Quarterly, go to:
http://www.vaccinequarterly.com
Back to top |
| |
|
|
8. |
AMA
offers physicians practical information on improving adolescent immunization
The website of the American Medical Association
(AMA) recently
added a self-study course on adolescent immunization to its
Roadmaps for Clinical Practice series. Titled "Improving
Adolescent Immunizations: A primer for physicians," the course
includes a monograph, continuing medical education
questionnaire, and pocket booklet.
The course material examines the new recommendations for
adolescent immunizations. Key concepts include adolescent "catch
up" immunizations and special adolescent populations. The course
provides information on the National Vaccine Injury Compensation
Program and the Vaccine Adverse Event Reporting System. At the
practice level, it reviews the following topics: payment,
maximizing rates of immunization, and ways to enhance
relationships with adolescents and their parents.
A collaboration between AMA and the Department of Health and
Human Services, the Roadmaps for Clinical Practice series is
intended to assist physicians in integrating disease prevention
and health promotion into routine clinical care.
To access "Improving Adolescent Immunizations," go to:
http://www.ama-assn.org/ama/pub/category/18393.html
Back to top |
| |
|
|
9. |
Two
comprehensive sharps injury prevention resources are available--one on CD-ROM,
the other for downloading
The CD-ROM "Sharps Injury Prevention" is
available from the
Public Health Foundation's Learning Resource Center. It contains
a 168-page workbook for designing, implementing, and evaluating
a sharps injury prevention program; customizable slide
presentations that provide an overview of sharps injury
prevention practices; and a brochure that urges healthcare
workers to be prepared, be aware, and dispose with care.
Alternatively, the workbook can be downloaded directly from the
CDC website.
To order the CD-ROM from the Public Health Foundation for
$14.50, go to:
http://bookstore.phf.org/product_info.php?cPath=69_58&products_id=618
To download the workbook at no cost from the CDC website, go to:
http://www.cdc.gov/sharpssafety and click on the pertinent links
in the left column.
Back to top |
| |
|
|
10. |
New: Interim VIS for MMR vaccine now available in Thai
Dated 3/13/08, the interim VIS for
measles-mumps-rubella (MMR)
vaccine is now available in Thai. IAC gratefully acknowledges
Asian Pacific Health Care Venture of Los Angeles for the
translation.
For a Thai version of the interim VIS for MMR vaccine, go to:
http://www.immunize.org/vis/th_mmr03.pdf
For an English version of the interim VIS for MMR vaccine, go
to:
http://www.immunize.org/vis/mmr03.pdf
For information about the use of VISs, and for VISs in more than
30 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
| |
|
|
11. |
PowerPoint presentations now available from the National Conference on
Immunization and Health Coalitions
PowerPoint presentations made at the National
Conference on
Immunization and Health Coalitions can now be downloaded. The
conference was held in San Francisco on May 21-23.
To access the presentations, go to:
http://www.sfimmunize.org/page4.html
Back to top |
| |
|
|
12. |
Seminar on CMI techniques standardization for vaccine response evaluation is
planned for September 15-17 in Annecy, France
A seminar on cell-mediated immunity (CMI)
techniques
standardization for vaccine response evaluation will be held
September 15-17 at Les Pensieres Conference Center, Annecy,
France.
For information on the seminar program and registration, go to:
http://www.fondation-merieux.org/?-Conferences,176- Scroll down
to the listing titled "15-17 September 2008."
For additional information, email Catherine Dutel at
catherine.dutel@fondation-merieux.org
Back to top |
| |
|
|
